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Abstract: The insulin signalling system is one of the most conserved endocrine systems of Animalia
from mollusc to man. In decapod Crustacea, such as the Eastern spiny lobster, Sagmariasus verreauxi
(Sv) and the red-claw crayfish, Cherax quadricarinatus (Cq), insulin endocrinology governs male
sexual differentiation through the action of a male-specific, insulin-like androgenic gland peptide
(IAG). To understand the bioactivity of IAG it is necessary to consider its bio-regulators such as the
insulin-like growth factor binding protein (IGFBP). This work has employed various molecular
modelling approaches to represent S. verreauxi IGFBP and IAG, along with additional Sv-ILP
ligands, in order to characterise their binding interactions. Firstly, we present Sv- and Cq-ILP2:
neuroendocrine factors that share closest homology with Drosophila ILP8 (Dilp8). We then describe
the binding interaction of the N-terminal domain of Sv-IGFBP and each ILP through a synergy
of computational analyses. In-depth interaction mapping and computational alanine scanning of
IGFBP_N’ highlight the conserved involvement of the hotspot residues Q67, G70, D71, S72, G91, G92,
T93 and D94. The significance of the negatively charged residues D71 and D94 was then further
exemplified by structural electrostatics. The functional importance of the negative surface charge
of IGFBP is exemplified in the complementary electropositive charge on the reciprocal binding
interface of all three ILP ligands. When examined, this electrostatic complementarity is the inverse
of vertebrate homologues; such physicochemical divergences elucidate towards ligand-binding
specificity between Phyla.
Keywords: insulin-like growth factor binding protein (IGFBP); insulin-like androgenic gland
peptide (IAG); insulin-like peptides (ILP1; ILP2); molecular modelling; binding interaction; alanine
scanning; hotspot residue; electrostatics; decapod
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1. Introduction
The binding interaction of insulin-like growth factor binding proteins (IGFBPs) and their
insulin-like growth factor (IGF) ligands has been a significant focus of IGF endocrinology for the
past two decades [1–3]. This is reflective of the central function of the high-affinity IGFBP subgroup
(IGFBP1-6) in mediating the bioavailability and activity of IGFI and II at their receptor(s) [1–3].
In doing so, IGFBPs not only facilitate the translocation of their binding partners but they also provide
proteolytic protection, extending the half-life and maintaining a functionally viable reservoir of the
hormone in circulation [1–3].
The structure of the IGFBP is central to this function. Although domain specifics of the superfamily
vary, most notably across the low-affinity IGFBP-related subgroup (IGFBP-rP1-9) [1], the family
conforms to a common architecture: a highly structured, globular N terminal (N’) insulin-binding
domain; a flexible linking domain; and a flexi-folded C terminal (C’) domain, which is the most variable
domain across subgroups and species [1,3]. The highly structured N’ insulin-binding domain (the only
domain conserved across the entire IGFBP superfamily) provides the primary binding interface for
the ligand and is capable of binding in isolation [4]. In the case of IGFBP1-6, the C’ domain functions
to maximise binding affinity, encapsulating the ligand to stabilise binding by interacting with the N’
domain [3,5,6]. In doing so, the C’ shields some of the key residues involved in the interaction of IGF
with its receptor, increasing the antagonistic action of the IGFBP [5]. This synergistic binding of N’ and
C’ domains is coordinated through the flexible linking domain [1].
We have identified an IGFBP homologue in the decapod crustacean Sagmariasus verreauxi,
commonly referred to as the Eastern spiny lobster [7], prior to which a similar protein was identified
in the red-claw crayfish (Cherax quadricarinatus) [8]. Additional homologues have since been found in
a prawn, Macrobrachium nipponense [9], and two crab species, Scylla paramamosain [10] and Callinectes
sapidus [11]. These decapod IGFBPs share closest homology with the human IGFBP-rP1 (known as
MAC25) from the low-affinity IGF-binding subgroup. They all share a kazal-type serine proteinase
inhibitor as the linking domain and an immunoglobulin-like domain as the C’ domain (rather than
the thyroglobulin-type I domain of human IGFBP1-6 [1]). Unlike IGFBP1-6, the binding capacity of
IGFBP-rP1 is more diverse, enabling it to bind insulin with a similar affinity as the IGFs, although
with a reduced affinity compared to its specialised (IGFBP1-6) counterparts [12]. This is thought to be
achieved through the substituted C’ immunoglobulin domain [1], which is proposed to reduce the
synergistic N’ and C’ domain high-affinity binding for IGFs, whilst also better exposing the insulin
binding site [13,14]. In addition, it has been recognised that although they share the same overall fold,
the N’ insulin-binding domain of this IGFBP-r subgroup contains notable structural variations from
IGFBP1-6, resulting in a decreased IGF binding affinity [15]. Thus some suggest that the IGF binding
of the IGFBP-r subgroup is biologically irrelevant [15,16], advising of a primary function unrelated to
IGF binding [17]. Even so, the general consensus appears to be that the IGFBP-r subgroup functions in
both IGF-dependent and independent roles [1,17].
In the context of the decapod IGFBPs, the homology with the less IGF-specific IGFBP-rP1 is likely
to have functional significance, relating to the ligands with which these decapod homologues bind.
The IGFs comprise one subgroup of the insulin-like superfamily, with the insulin-like peptides (ILP)
encompassing the other [7,18]. The structural distinction centres around the pre-prohormone structure
and processing. IGFs tend to retain their truncated C-domain and have additional D (uncleaved) and
E (cleaved) domains after the A-chain [2,19,20]. ILPs undergo cleavage of the C-peptide and terminate
after the A-chain [7,18]. However, both IGFs and ILPs share the same disulfide bond topology, with two
inter (B to A) and one intra (A)-chain bonds [18,20].
IGF homologues have not yet been identified in decapods, but the Crustacean class Malocastraca
(which includes the Order Decapoda) is known for an ILP termed the insulin-like androgenic
gland peptide (IAG). This hormone, only found in males (with noted exceptions [21,22]),
is specifically produced and secreted from a male-specific endocrine gland known as the androgenic
gland (AG) [23–25]. Upon secretion, IAG stimulates and maintains the broad tissue effects of male
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sexual differentiation and maturation [26–30], reviewed in [31]. More recently, the prevalence of ILPs
in these species has diversified with the first identification of a DILP7/relaxin-like ILP in S. verreauxi
(Sv-ILP1) [7], since identified across the Order [32].
Work in C. quadricarinatus has already demonstrated the capacity of Cq-IGFBP to bind Cq-IAG
through a pull-down assay with AG homogenate, where the IGFBP was shown to bind residues
within the A-chain, B-chain and C-peptide; highlighting the ability of the IGFBP to also bind the IAG
pre-prohormone [8]. The IGF/ILP receptor signalling system, as characterised in mammals [2,3] and
Drosophila [33], is conserved in decapods (as evidenced by the identification of an active tyrosine
kinase insulin receptor (TKIR) [34,35] and an inactive decoy (TKIR_decoy) [34]). Consequently,
it seems highly likely that the IGFBP will adopt a similarly conserved role within the system. Thus,
to realistically interpret the bioactivity of IAG in mediating male sexual development, we must
integrate the regulatory influences of the IGFBP. Furthermore, the identification of additional ILPs [7]
and the broad tissue distribution of the IGFBP [7,8,10,11] in the decapods may suggest a multi-ligand
binding role.
In light of the dramatic advancements that have been made in the field of computational
protein-modelling and interaction studies [36,37], this work employed an in silico approach to study
the IGFBP_N’-ILP ligand interaction in decapod Crustacea. Firstly, we present Sv-ILP2 and Cq-ILP2,
which are novel to the Order. We then model the N’ domain of Sv-IGFBP and each ligand (Sv-IAG, ILP1
and ILP2) in order to characterise the binding interaction of each. In doing so we determine a subset of
consistently interacting residues at the IGFBP interface, involved in binding all three ligands, which
are further suggested to be hotspots based on computational alanine scanning. Electrostatic potential
surface calculations illustrate the significance of the negatively charged hotspots, suggesting them to
be a fundamental feature of complex formation. Together, these analyses emphasise the consequence
of amino-acid variations in determining the physicochemical structure and consequential binding
interactions of the seemingly conserved N’ insulin-binding domain of the IGFBP.
2. Results
2.1. Identification of Sv-ILP2
This work is the first to describe the identification of a second insulin-like peptide in S. verreauxi,
Sv-ILP2 (KP006646). Sv-ILP2 conforms to the ILP superfamily structure exhibiting all of its conserved
features: a signal peptide (20 amino acids (aa)); followed by a B-chain (28 aa) containing two cysteines;
a C-peptide (71 aa), flanked by RR cleavage sites; and an A-chain (17 aa) containing a double and
two single cysteines (Figure 1a). Interestingly, unlike Sv-IAG and Sv-ILP1, Sv-ILP2 contains multiple
RR cleavage sites throughout the C-peptide. These additional chains are somewhat reminiscent of
the additional D and E domains of the IGF-like pre-prohormone structure. However, as the CCxxxC
cysteine signature is located in the C’ domain of the open reading frame it was considered to be the
A-chain, suggesting these additional cleavage sites constitute an elongated C-peptide; we therefore
classified Sv-ILP2 as an ILP rather than an IGF.
Spatial expression analyses of Sv-ILP2 (Figure 1b) show it to be predominantly expressed in the
neuroendocrine tissues (brain and eyestalk) of males and females, although all RPKMs are low (RPKMs
as follows: female eyestalk 1.15; male eyestalk 0.8; male brain 0.39; immature AG 0.2). Temporal
RT-PCR analyses were also conducted (from phyllosoma instar 16 to puerulus) but Sv-ILP2 expression
was not identified (data not shown). When blasted at NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi),
neither the pre-pro nor mature hormone gave any significant hits, although our phylogenetic analyses
(with a range of model ILPs) shows that Sv-ILP2 clusters with Dilp8 (Figure 1c). Thus, Sv-ILP2 is the
first of a new subclass of ILPs to be described in the decapods.
This work also presents two homologues of Sv-ILP1 and ILP2 (S. verreauxi, Suborder Achelata) in
the red-claw crayfish, C. quadricarinatus (Suborder Astacidea); we have therefore named these peptides
Cq-ILP1 (KP006644) and Cq-ILP2 (KP006645) (Figure 1c). Cq-ILP1 is comprised of: a signal peptide
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(25 amino acids (aa)); a B-chain (37 aa); a C peptide (115 aa); and an A-chain (37 aa). Cq-ILP2 is
comprised of a: signal peptide (25 aa); a B-chain (29 aa); a C-peptide (159 aa); and an A-chain (17 aa).
When assessed by RT-PCR, the Cq homologues display similar spatial expression to that described
in S. verreauxi, with Cq-ILP1 present in the male and female brain, antennal gland, gonads, and the
female, but not male hepatopancreas, while Cq-ILP2 expression is specific to the male and female brain
and thoracic ganglia (no expression in the eyestalk) (data not shown).
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is underlined in red and the B-(blue) and A-(orange) chains boxed with the cysteine core of each
highlighted. The C-peptide is shown in grey with the predicted Arg-C cleavage sites shown,
with those predicted to generate the mature hormone underlined in red. (b) Transcriptomic spatial
expression of Sv-ILP2 quantified as reads per kilobase per million reads (RPKM) for male and female
brain (BR), eyestalk (ES), gonads (TS and OV), antennal gland (AnG), and fifth walking leg (5WL),
immature androgenic glands (I_AG1 and I_AG2), and mature androgenic glands (AG1* and AG2,
where * indicates a hypertrophied gland). Validated with spatial RT-PCR analyses, with the removal
of the immature AGs, 5 L, and AG1*, and the addition of male and female hepatopancreas (HP).
Negative control (NC) in the fifteenth lane, 16S as positive control. (c) Neighbour-joining phylogram
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2.2. Sequence Analyses of IGFBPs and ILP Ligands
We conducted pairwise alignment of the IGFBP, IAG, ILP1, and ILP2 peptides from S. verreauxi
and C. quadricarinatus to assess physicochemical conservation. The IGFBP sequences share a pairwise
identity score of 68.9% and significant conservation in physicochemical properties (Figure 2a).
With regard to the ligands, the IAG peptides share the lowest identity score of the three ILPs,
at 32.2% across the pre-prohormone and 35.5% across the mature hormone (consisting of only the
A and B-chains) (Figure 2b). The ILP1 homologues share the highest conservation at 64.6% across
the pre-prohormone and 83.1% across the mature hormone (Figure 2c). This high identity score is
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fitting with the strong conservation of this relaxin-like ILP subclass across species (also known as the
Dilp7-likes characterized in Drosophila).
The ILP2 homologues share an identity score of 44.6% at the pre-prohormone level,
which increases to 57.8% for the mature peptide (Figure 2d). As previously mentioned, we surmise
that the final cleavage site indicates the beginning of the A-chain, based on the structural placement of
the cysteines but also reflective of the increased conservation observed between the Sv- and Cq-ILP2
homologues in this C’ domain. These sequence alignments exemplify the minimized evolutionary
restraint within the C-peptide, showing far higher rates of divergence than that observed in the A and
B-chains which ultimately form the mature and active hormone.
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Figure 2. Sequence alignment of Sagmariasus verreauxi and Cherax quadricarinatus IGFBP and ILP
homologues, ith on the conservation of physicochemical properties. Residues a
colored in accordance with rop rties: red—define small, ydrophobic residues; blue—negatively
charged/acidic; magenta—positively charged/basic; and gre n—polar and amine groups. An asterisk
(*) indicates a conserved i i , colon (:) those with conserved physicochemical prop rties,
and a full stop (.) those ith weakly similar properties. (a) Compares Cq-IGFBP and Sv-IGFBP,
the signal peptide is un erlined in red, the insuli -binding domain boxed in blue with t e cysteine core
highlighted, the kazal domain underlined in pur le, and the C’ immunoglobulin domain boxed in grey.
(b) Compares Cq-IAG and Sv-IAG; (c) Sv-ILP1 and the novel Cq-ILP1; and (d) the novel Sv-ILP2 and
Cq-ILP2. In each case the signal peptide is underlined in red and the mature hormone is highlighted
as the B-(blue) and A-(orange) chains with the cysteine core of each highlighted; C-peptide Arg-C
proteinase cleavage sites are underlined in red.
To provide a ore c esi e ersta i of the insulin-signaling system in S. verreauxi,
we generated a spatial expression profile sum arizing all of t e i s li factors identified in the species
to date (Figure 3), namely, Sv-IAG [38]; Sv-IGFBP and Sv-ILP1 [7]; Sv-TKIR and Sv-TKIR_decoy [34,39];
and Sv-ILP2, presented in this work (all RPKMs have been validated with indepe ent RT-PCR,
some with additional in situ a alyses; related references given above after each gene). Of ote is the
broad tissue distribution of Sv-IGFBP and the dramatically higher expression of IAG relative to all
other endocrine factors. However, this expression must be considered in the context of localization,
as IAG is secreted by a relatively small subset of cells, all of which are accounted for in this one gland.
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ILP1 and IGFBP [7]; the active (TKIR) and decoy (TKIR_decoy) tyrosine kinase insulin receptors [34,39];
and Sv-ILP2. Quantified as RPKM; tissue abbreviations as previously described.
2.3. Structural Modelling
S ructures of Sv-IGFBP (3TJQ and and Sv-IAG, Sv-ILP1 and Sv-ILP2 (2KQP) were pr dicted
by homology modelling using the described PDB templates. The predicted struct re of Sv-IGFBP
provides clear visualization of the do ai of the molecule (Figure 4a). The highly
s ructured N’ insulin-b ding domain contains s ven disulfide bonds, ensuring a curate folding of the
bi i i terf . e kazal i , fi fl and
’ domains, contains an alpha helical region and one disulfide bond. The C’ immunoglobulin domain
also contains disulfide bond, as well as a ci -peptid bond, but lacks ny other significa t orienting
features and is mainly comprised of beta pl ated sheets and random coils.
Each ILP ligand conforms to t e charac eristic tertia y s ructure of the ILP family with two inter
and o e intra (A-chain) disulfide bonds hat determine the overall fold of the molecule (Figure 4b–d).
i confines of the gen ric ILP fold, each protein displays unique features. Th most prominent
of these include the elongated A-chain of Sv-ILP1, which does n t form the usual alpha-helix but
instead a random c il (Figure 4c; Figure S1). Conversely, Sv-ILP2 has a truncated A-chain, where
the r sidues 1QCCV4 result in an alpha turn rather than a complete helix ( i r ; S1).
t and Figure S1 for full modelling procedures. It is these features tha determin the
specifics of the interactive interface shared between the A- and B-chains, d ctating the mo ecular
s ructur of each ligand. This is best illustrated by he inter-chain interac ions: the A- and B-chains
of IAG, ILP1, and ILP2 are predicted to share one, thre , and one hydrogen bonds and 153, 109,
and 74 non-bonded contacts, respectively, i addition to the two isulfide bonds common to all three
(predicted by PDBsum) (Figure S2).
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Figure 4. Molecular structure models of (a) Sv-IGFBP, the domains of which are indicated with: a blue
bracket for the highly structured N’ insulin-binding domain; a purple bracket for the linking kazal
domain; and grey bracket for the C’ immunoglobulin domain. (b) Sv-IAG, (c) Sv-ILP1, and (d) Sv-ILP2
are shown as previously described with the A-chain in orange and B-chain in blue. All structures are
shown in secondary structure ribbon format with disulfide bonds highlighted as sticks.
2.4. Complex Formation
Complex formation and protein-protein interactions were then investigated through both manual
structural alignment and predictive binding analyses. Due to the reduced reliability of modelling the
bound C’ immunoglobulin domain, Sv-IGFBP was truncated after the kazal domain (Sv-IGFBP_N’)
(as is common in IGFBP binding studies [40,41]; PDB: 1H59 [42]; PDB: 1WQJ [5]). Sv-IGFBP_N’
was used for all further interaction studies. We collated manual alignment analyses, with predicted
binding interactions generated through PDBsum [43] and PRODIGY [44] to generate an interaction
map of all the residues involved in complex formation (Figure 5). Visual comparison of the three
Sv-IGFBP_N’ complexes (Figure 5a) clearly demonstrates the binding interface of the N’ insulin-binding
domain (supported by HADDOCK2.2 simulations: Figure S3), with all highlighted interacting residues
predicted by both PDBsum and PRODIGY (shown in Figure 5b; additional residues predicted by
PRODIGY presented in Table S1). Of all the predicted interacting residues presented in Figure 5b,
we have highlighted those amino acids of IGFBP_N’ that show conserved interaction contacts with
all three ligands (*), namely: the negatively charged Asp(D)71 and Asp(D)94; supported by the
polarGln(Q)67 (where proton acceptor properties enable it to form two hydrogen bonds, stabilizing
the overall negative charge); the neutrally charged Ser(S)72 and Thr(T)93; and Gly(G)70, Gly(G)91,
and Gly(G)92. In addition to these eight consistent contacts of IGFBP_N’, PRODIGY predicts a further
nine (Table S1). The physicochemical nature of each interaction as predicted by PRODIGY suggests
that a relatively even contribution of charged, polar, and non-polar interactions contribute to binding,
with charged forces slightly dominating with IAG and ILP1 and hydrophobic forces being slightly
dominant with ILP2 (Table S1b).
Int. J. Mol. Sci. 2017, 18, 1832 8 of 19




Figure 5. Molecular structure models of bound complexes and interaction map: (a) Complex of Sv-
IGFBP_N’ with each ligand. In each case the IGFBP_N’ is in green and the ligand in orange (A-chain) 
and blue (B-chain). All residues involved at the binding interface are indicated in stick, with colouring 
as previously described. (b) Interaction map describing residue-specific interactions between Sv-
IGFBP_N’ and each ligand. Standard amino acid abbreviations are used, with colours indicating 
physicochemical properties as follows: blue—positive, red—negative, green—neutral, grey—
aliphatic, mauve—aromatic, orange—proline and glycine, and yellow—cysteine. Number of 
interacting residues is given in brackets; an asterisk denotes those residues that show a conserved 
binding interaction with all three ligands (n = 8). 
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increases as the degree of buriedness of a residue decreases (due to shape complementarity); it 
increases if a given residue forms a salt bridge, and hotspot residues tend to show structural and 
interactive complementarity to that of their binding partners. In brief, alanine scanning is conducted 
by mutating each residue in the complex to alanine, removing the sidechains that are fundamental to 
its physicochemical and interaction properties. The binding free-energy is then calculated and 
compared to the wild-type. In doing so, those residues that contribute most significantly to achieving 
the binding energetics of complex formation are determined. This work used five independent 
Figure 5. Molecular structure models of bound complexes and interaction map: (a) Complex of
Sv-IGFBP_N’ with each ligand. In each case the IGFBP_N’ is in green and the ligand in orange
(A-chain) and blue (B-chain). All residues involved at the binding interface are indicated in stick,
with colouring as previously described. (b) Interaction map describing residue-specific interactions
between Sv-IGFBP_N’ and each ligand. Standard amino acid abbreviations are used, with colours
indicating physicochemical properties as follows: blue—positive, red—negative, green—neutral,
grey—aliphatic, mauve—aromatic, orange—proline and glycine, and yellow—cysteine. Number of
interacting residues is given in brackets; an asterisk denotes those residues that show a conserved
binding interaction with all three ligands (n = 8).
2.5. Interaction Hotspots
As the IGFBP_N’ is predicted to contain a subset of consistently interacting residues when in
complex with all three ligands, the energy contributions of these residues were investigated using
computational alanine scanning to highlight binding hotspots. A hotspot is defined as an amino
acid that significantly decreases the binding free-energy of complex formation. As a rule: hotspot
potential increases as the degree of buriedness of a residue decreases (due to shape complementarity);
it increases if a given residue forms a salt bridge, and hotspot residues tend to show structural and
interactive complementarity to that of their binding partners. In brief, alanine scanning is conducted by
mutating each residue in the complex to alanine, removing the sidechains that are fundamental to its
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physicochemical and interaction properties. The binding free-energy is then calculated and compared
to the wild-type. In doing so, those residues that contribute most significantly to achieving the binding
energetics of complex formation are determined. This work used five independent algorithms to
generate a meta-style analysis. These hotspot predictions are in strong support of our predicted
interactions, with all the consistently interacting residues predicted by both PDBsum and PRODIGY
being identified as hotspots (Figure 6a). Furthermore, of the additional predicted hotspots, four of the
seven residues were predicted as consistently interacting residues by PRODIGY (denoted with a P in
Table S1). Together, this allows confident prediction that these residues are vital to the binding capacity
of IGFBP_N’, suggesting a synergistic physicochemical influence of negative charge, polar neutral
residues, and glycine. Figure 6b shows the sequence positioning of these residues, which appear to
cluster into two defined regions as hotspot pockets, which, at the structural level, orientate across the
exposed binding interface (Figure 6c).
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Figure 6. Identification of hotspot residues: (a) determined by five independent alanine scanning
algorithms. Amino acids are shown in standard letter notation. Other notation is as follows: an asterisk
(*) indicates the presence of a salt bridge predicted by PDBsum; a dash (‘) a salt bridge predicted by
Cpclab; bold underlined indicates residues that show a conserved binding interaction with all three
ligands (see Figure 5b). (b) Illustration of Sv-IGFBP_N’ sequence (insulin-binding domain boxed in blue
and kazal domain underlined in purple) highlighting the positioning of predicted hotspots. The eight
consistently interacting hotspot residues are in bold underline. Additional predicted hotspots are also
listed, with a P highlighting those residues that were predicted as consistently interacting residues
by PRODIGY. (c) Structural illustration of Sv-IGFBP_N’ with conserved interacting hotspot residues
highlighted in ball and stick and additional hotspots in stick. Throughout, red indicates negatively
c arged residues; green, neutrally charged; and orange, glycine. Note the neutral Gln(Q) has been
underlined in red i (b) sequ nce and coloured red in (c) str cture due to its role in stabilizing th
ov rall negative charge through the formation of ydrogen bonds.
2.6. Electrostatic Potential olecular Surfaces
Considering the conserved prevalence of negatively charged residues throughout the hotspot
predictions, e conducted an electrostatic potential surface analysis to further investigate the
significance of these negatively charged residues. Figure 7a shows the electrostatic potential surface
of the IGFBP_N’-IAG complex and the binding interfaces of each individual molecule, as well as
the additional ligands, ILP1 (Figure 7b) and ILP2 (Figure 7c). The binding interface of Sv-IGFBP_N’
is indeed characterized by a strong negative electrostatic potential. The co ple entary positive
electrostatic potential that exists on the reciprocal interface of all three ligands is in support of
an electrostatic interaction. Considering the sequence conservation of Sv-IGFBP and Cq-IGFBP
(Figure 2a), we performed similar analyses on Cq-IGFBP_N’. Indeed, the negative electrostatic potential
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of the predicted binding interface is conserved to Cq-IGFBP_N’, as is the broader physicochemical
nature of 13 of the 15 interaction hotspots characterized in Sv (Figure 8). Of note is the Glu(E)70
substitution in Cq (replacing the Gln(Q)67 of Sv) emphasizing the suggested negative-centered
properties of this residue in Sv. This is indicative of conserved interactive properties and the resulting
binding mechanism of the two IGFBP_N’ of these species.Int. J. Mol. Sci. 2017, 18, 1832  10 of 19 
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For evolutionary comparison, we conducted electrostatic potential surface calculations on
the template complexes IGFBP4_N’ and IGFI (PDB: 1WQJ) (Figure 9a), and IGFBP5_N’ and IGFI
(PDB: 1H59) (Figure 9b), as well as IGFII (PDB: 2L29) (Figure S4), and found that these human
complexes (positive electrostatic potential on the IGFBP and negative on the ligand) display inverse
complementary electrostatic potentials to those described in S. verreauxi and C. quadricarinatus (negative
electrostatic potential on the IGFBP and positive on the ligand). We then proceeded to conduct
electrostatic potential surface calculations on a range of publicly available vertebrate IGFBP1_N’ and
IGFI structures. All of those analyzed (namely rat, cow, chicken, for which IGFBP2_N’ replaced
IGFBP1 and salmon) display a similar electrostatic potential complementarity to that observed in
human, with a positive (IGFBP) and negative (IGF) electrostatic potential (data not shown). Thus,






Figure 9. Electrostatic potential surface in vertebrates: (a) the bound complex and individual binding
partners of human IGFBP4_N’-IGFI (PDB: 1WQJ); and (b) human IGFBP5_N’-IGFI (PDB: 1H59). In both
cases the IGFBP_N’ is coloured in blue and the IGFI in green. Surfaces are colored by potential on the
solvent accessible surface on a scale of −kT/e (red) to +kT/e (blue), as indicated by the scale bar.
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3. Discussion
The interaction studies conducted in this work provide structural and physicochemical evidence
for the capacity of IGFBP to bind the ILP ligands identified in S. verreauxi. By comparing Sv002D-IGFBP
with a homologous IGFBP from C. quadricarinatus (a member of the sister Suborder Astacidea),
we highlight the conservation of these physicochemical properties, suggesting a similar binding
interaction to be conserved. These structural studies are indicative of a conserved function of the
IGFBP in the insulin endocrine system of these decapods.
The contacts that occur at the binding interface are the fundamental features that dictate a binding
interaction and, critically, its stability [45]. This makes in silico analyses such as these a highly
suitable method to investigate and visualise molecular binding. Furthermore, the development of
computational alanine substitution has provided significant insight into the energetic contributions
of the binding interface [45,46], most significantly highlighting that only a few key residues—
the hotspots—are those that contribute most significantly to the binding free-energy of complex
formation [45]. Our analyses of Sv-IGFBP_N’ agree with this, firstly identifying those residues that are
involved in interaction contacts with all three ligands (Figure 5b) and then verifying their significance
as interaction hotspots. Hotspot residues tend to cluster in pockets within the centre of the exposed
binding interface [45]. This is true of our predicted hotspots, which show close structural orientation
across the exposed centre of the N’ domain (Figure 6c).
The physicochemical nature of these conserved interacting hotspots (Q67, G70, D71, S72, G91, G92,
T93 and D94) suggests that a range of contact properties exist at the binding interface (supported by the
PRODIGY contact predictions; Table S1b). In particular, we illustrate the significance of the negatively
charged hotspots, providing a structural illustration of the negative charge of the entire Sv-IGFBP_N’
binding interface. Taken with the complementary positive charge of the reciprocal interface of each ILP
(Figure 7), it appears that complex formation occurs, at least in part through an electrostatic interaction.
Electrostatic interactions promote complex affinity through hydrogen bonding and in certain cases,
such as that predicted for Asp(D)71 in complex with ILP2 (Figure 5b), salt bridge formation, adding
significant stability to the bound complex.
However, any binding interface is achieved through a complex synergy of molecular
interactions [45]. For example, hydrophobicity has been repeatedly described as the interactive
force in IGFBP_N’-IGF complexes. Studies with human IGFBP5_N’ [42] and IGFBP4_N’ [6] highlight
the conserved importance of the hydrophobic residues (Val49/48, Leu70/69, Leu74/72). This hydrophobic
patch is conserved across all six IGFBP_N’ [47] and has been mutated in IGFBP3-6_N’, resulting in
a ~1000 fold decrease in binding affinity [40,41,48–50]. The solved complex of IGFI with IGFBP5_N’
further verified the hydrophobic interaction, evident through the interwoven hydrophobic contacts of
protruding side chains [42], also described for IGFBP4_N’ [5,6]. Of the above, the only mention
of electrostatic properties comes from IGFBP3_N’ and 5_N’, where the electropositive residues
Lys68/Arg69 were also highlighted as critical for high-affinity binding [40,41]. It is only more recently
that the role of electrostatic interactions has been established. Chen et al., (2014) [51], conducted
computational alanine scanning of IGFI to select mutation hotspots in order to conduct comparative
molecular dynamic simulations. Five of the six determined hotspots were negatively charged
(three Glu(E) and two Asp(D)) and electrostatic interactions were determined to be the dominant
driving force behind the IGF-IGFBP interaction [51]. These simulations are in strong support of our
electrostatic potential surface analyses, which describe an electropositive (IGFBP) to electronegative
(IGF) complementarity in vertebrates (Figures 9 and S4).
It follows that residues across the binding interface coevolve, acquiring binding pockets enriched
with amino acids that ensure an interdependent binding interaction [45]. Such coevolution is evident
in the significant sequence conservation between Sv and Cq-IGFBP, and further still by the inverse
electrostatic complementarity that we have observed between the crustacean (Figures 7 and 8) and
vertebrate (Figures 9 and S4) IGFBP_N’-ligand complexes. Rosen et al., (2013) [8], found that Cq-IGFBP
was not able to bind human insulin and could only weakly bind human IGFI. This emphasises that
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although the conserved cysteine architecture of the IGFBP_N’ family coordinates the same overall
fold [1,15], it is the specific properties of amino acids, particularly the interaction hotspots, that govern
side-chain interactions [15] and thus the binding capacity for any given ligand. Indeed, the same
has been noted with the evolutionary conservation of the insulin receptor and its interactions with
insulin [52].
A structural comparison of the bound Sv-IGFBP_N’ complexes suggests that a similar interaction
is shared across all three ligands. Binding affinity predictions varied, with PRODIGY [43,44]
and PYDOCK [53] showing no significant distinction and ROSETTADOCK [54] indicating
an ILP1 > IAG > ILP2 affinity pattern and FIREDOCK [55] an ILP2 > ILP1 > IAG pattern. Thus,
no reliable affinity prediction can be determined; however, taken with our structural studies, it can
be stated that Sv-IGFBP_N’ appears to lack a selective affinity for any of these ligands, similar to
that described for IGFBP-rP1 with insulin, IGFI, and IGFII [12]. The inability to generate consistent
predictions of relative binding affinity is partly due to the intrinsic error in the computational prediction
of binding affinities but also reflects the use of a molecular model of the isolated IGFBP_N’. Indeed,
this is a common problem in IGFBP structural studies. Although well aware of the interactive nature
of the IGFBP_N’ and C’ domains in the mediation of binding affinity, the N’ insulin-binding domain
remains the focus of structural and affinity studies, mainly due to the poor ability to solve the flexible
linking domain [51]. Yet, as we are well aware of the synergistic function of the N’ and C’ domains
in mediating affinity [3,6], we must strive to generate interaction studies of the entire protein [37] in
order to gain accurate in silico quantification of IGFBP binding affinity across ligands.
In a practical context, these in silico proof-of-binding studies suggest that these decapod IGFBPs
may offer a distinct mode to regulate the bioavailability and consequential activity of IAG. The use
of RNAi biotechnologies employing IAG to induce sex-reversal for the monosex population culture
has been highly successful in the commercial decapod M. rosenbergii [56,57], with similar research
practices occurring across commercial species. Molecular evidence for the interconnected nature of
the IGFBP and IAG was demonstrated by Li et al., (2015) [9], who showed that the silencing of IAG in
M. nipponense caused a ~50% reduction in the expression of the IGFBP (so named IAGBP). However,
although this is evidence of a transcriptional interaction, when interpreted in the context of this work
these conclusions may be somewhat misleading. This is most evident in the naming of the IGFBP as
an IAGBP, suggesting specificity. This study clearly demonstrates the capacity of the IGFBP to bind
non-IAG ILPs. Indeed, the finding that IAG silencing only resulted in a significant decline of IAGBP in
the AG, testis, muscle, and hepatopancreas, but not in the neuroendocrine tissues of brain, eyestalk,
and nerve cord is evidence for a maintained function of the IAGBP in these tissues. As we show both
ILP1 [7] and ILP2 (this study) to express in neuroendocrine tissues, perhaps the maintained expression
of “IAGBP” in the neuroendocrine tissues of M. nipponense is evidence of an unaffected interaction with
additional ILPs. This is further supported by the increasing evidence of additional ILP1/relaxin-like
ILPs in the decapods [32], which are likely to share a similar binding interaction with their IGFBPs.
Thus, we caution against employing IGFBP as a target for IAG manipulation, as it is likely to induce
off-target effects across the broader insulin endocrinology of these species. In the context of IAG
regulation, additional bio-regulators may provide a more specific anti-protease action, such as the
family of AG enriched α2-macroglobulins [58] identified through their >5× higher expression in the
AG relative to all other tissues [59].
Moreover, the IGF-independent action of the IGFBP superfamily (most significantly the IGFBP-r
subgroup) is not to be ignored [3,17]. Thus, an ILP-independent functionality of these decapod IGFBPs
is very probable; an example being the immunological function investigated by Huang et al., (2016) [11].
When one considers the unspecified IGF/insulin binding capacity of IGFBP-rP1, as well as its ligand
independent functions [1], perhaps these homologous decapod IGFBPs [7–11] (which are the only
IGFBP subtype to be identified in the Order) are the multi-functional, unspecified ancestors of the
superfamily described in vertebrates. Multiple modes for the evolution of the IGFBP family have
been suggested, but establishing the evolutionary trajectory of this diverse superfamily is complex,
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with the only pronounced feature being the early emergence and conservation of the N’ insulin-binding
domain [1].
In summary, this work has added novel evolutionary perspectives to the IGFBP superfamily,
demonstrating the conserved functionality of an IGFBP-rP1 homologue in binding multiple insulin-like
ligands in a decapod crustacean. This constitutes further evidence for the conserved nature of the
insulin-signalling system in decapod species. By employing molecular modelling approaches we have
assessed the structural, but more importantly, the physicochemical nature of the IGFBP_N’. In doing
so, we suggest that these physicochemical characteristics are at the core of the IGFBP_N’ divergences
across species. The inverse electrostatic complementarity that we illustrate to exist between the
decapod and vertebrate IGFBP_N’-ligand complexes is evidence of such. These dramatic divergences
likely justify the specificity of ligand binding between Phyla.
4. Materials and Methods
4.1. Sequences
In addition to the previously described sequences for Sv-IAG (KF220491.1), Sv-ILP1 (KP006643),
and Sv-IGFBP (KU195720), this work is the first to describe a second insulin-like peptide in S.-verreauxi,
Sv-ILP2 (KP006646), as well two homologues in C. quadricarinatus, so named Cq-ILP1 (KP006644) and
Cq-ILP2 (KP006645). Sequences were mined from transcriptomic data using a Java script for the conserved
cysteine residue motif (using CLC (v7.5.1)). All sequences have been submitted to NCBI Genbank
(Accession Numbers given in brackets). Phylogenetic analyses were conducted with mature ILP sequences
(removal of signal and C-peptide) in Mega (7.0.21), aligned by Muscle and trees constructed using the
neighbour-joining method with 1000 bootstrap replicates. This work also uses the C. quadricarinatus IGFBP,
Cq-IGFBP (KC952011.1), and Cq-IAG (ABH07705.1). Sequence alignment and physicochemical analyses
were conducted using Clustal2.1 (http://www.ebi.ac.uk/Tools/msa/clustalo/).
4.2. Protein Structure Modelling
Sequences for Sv-IGFBP, Cq-IGFBP, Sv-IAG, Sv-ILP1, and Sv-ILP2 were submitted to LOMETS
http://zhanglab.ccmb.med.umich.edu/LOMETS [60] to select the closest resolved structures available
from the Protein Data Bank (PDB) to serve as structural templates. Models were based on the following
templates: Sv- and Cq-IGFBP insulin binding and kazal domains on IGFBP-rP5, also known as HTRA1
(PDB: 3TJQ_A), and the immunoglobulin domain on a myosin light chain kinase (PDB: 2CQV_A).
Sv-IAG, Sv-ILP1, and Sv-ILP2 were constructed based on insulin (PDB: 2KQP_A). In addition, each
sequence was analysed using Network Protein Sequence Analysis, Consensus Secondary Structure
Prediction meta-server (https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_
seccons.html), to detect any structural variances from the chosen template, which were then specifically
applied to each sequence (refer to Figure S1 for full details on modelling procedure).
The sequence alignments were imported into Discovery Studio 4.0 (Biovia; Accelrys Inc.,
San Diego, CA, USA) for model construction. Each protein model was generated using the “Build
Homology Model” by MODELER [61], implementing the disulfide bond criteria and any secondary
structure restraints (refer to Figure S1). In the case of Sv-IGFBP, an additional cis-peptide bond was
defined in the C’ immunoglobulin domain. In each case, the optimal model was selected via its lowest
energy and associated DOPE score [62] (Sv-IGFBP, −14117.9; Cq-IGFBP, −8248.2; IAG, −7841.97, ILP1,
−10224.5, ILP2, −6622.85). For the ILPs the C-peptide was kept intact for modelling (as it is likely
to be involved with orientation and folding) and later removed. Due to the flexible structure of the
IGFBP C’ immunoglobulin domain, truncated models (IGFBP_N’) consisting of the insulin-binding
and kazal domains were generated for Sv (truncated at R153) and Cq (truncated at R155) and used for
subsequent analyses.
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4.3. Molecular Docking and Binding Studies
For interaction studies, Sv-IGFBP_N’ and each ligand were imported to the Matchmaker module
in UCSF Chimera (http://www.rbvi.ucsf.edu/chimera) and aligned to the resolved, bound structure of
IGFBP4_N’ and IGFI (PDB: 1WQJ). The resulting bound models were saved relative to the template and
reimported to Discovery Studio. Each complex was then individually refined by energy minimisation
(using the CHARMm force field) to reduce steric clashes. For interaction assessment, refined complexes
were then submitted to PDBsum Generate, (http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/
Generate.html), PRODIGY [43,44] (http://milou.science.uu.nl/services/PRODIGY/), CCharPPI [63]
(https://life.bsc.es/pid/ccharppi), and then reanalysed manually in Chimera to validate interacting
residues. To assess the reliability of our modelled complexes, structures were also submitted
to HADDOCK2.2: Easy interface (http://milou.science.uu.nl/services/HADDOCK2.2) [64,65] to
generate comparative docked complexes.
4.4. Alanine Scanning and Hotspot Residues
We employed computational alanine scanning to determine the hotspot residues of
Sv-IGFBP_N’. This was done by replacing each residue in turn with alanine (the smallest
most inert amino acid) and assessing for a significant decrease in the binding free-energy [46].
We submitted each refined bound complex to five software platforms to gain a meta-style output:
Cpclab (http://cpclab.uni-duesseldorf.de/dsppi/) [66]; Robetta (http://www.robetta.org/
alascansubmit.jsp) [67]; KFC (http://kfc.mitchell-lab.org/) [68]; ANCHOR (http://structure.pitt.
edu/anchor/upload/); and HotRegion (http://prism.ccbb.ku.edu.tr/hotregion/) [69]. In addition,
the electrostatic interaction of each Sv complex, Cq-IGFBP_N’ and a range of vertebrate structures
was determined by performing electrostatic potential surface calculations using PDB2PQR [70] and
APBS [71] programmes within UCSF Chimera (with protonation states at physiological pH and 298 K
and parse charges). The surface potential representation is shown in each figure, with charge levels
ranging from −kT/e (red) to +kT/e (blue), as indicated by the scale bar.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/9/1832/s1.
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Cq Cherax quadricarinatus (red-claw crayfish)
Dilp7 Drosophila ILP7
Dilp8 Drosophila ILP8
IAG Insulin-like androgenic gland peptide
IGF Insulin-like growth factor
IGFBP Insulin-like growth factor binding protein
IGFBP-rP1 Insulin-like growth factor binding- related protein
ILP Insulin-like peptide
N’ N terminal
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RPKM Reads per kilobase per million reads
Sv Sagmariasus verreauxi (Eastern spiny lobster)
TKIR Tyrosine kinase insulin receptor
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